C
Harmony Biosciences Holdings, Inc. HRMY
$38.05 $0.882.37% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income 243.16% 18.85% 85.95% 19.84% -66.21%
Total Depreciation and Amortization -1.40% -2.55% -2.56% -2.26% -0.20%
Total Amortization of Deferred Charges -7.39% -7.78% -8.65% -85.99% -58.49%
Total Other Non-Cash Items -49.33% 19.40% -65.85% -37.85% 1,072.09%
Change in Net Operating Assets 193.01% -27.23% -50.02% 73.96% -105.03%
Cash from Operations 86.14% 9.14% -1.44% 11.73% 14.99%
Capital Expenditure 99.37% -2,460.00% -379.44% -- -208.29%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- 100.00% -- --
Divestitures -- -- -- -- --
Other Investing Activities 7.42% 140.28% -761.45% 192.00% -179.61%
Cash from Investing 64.29% 138.18% 80.07% 191.64% -605.91%
Total Debt Issued -- -- -- -- --
Total Debt Repaid 0.00% 0.00% 0.00% 98.09% -650.00%
Issuance of Common Stock 265.97% 3,956.90% 1,325.99% 955.33% -15.11%
Repurchase of Common Stock -284.01% -- 95.54% 100.00% 47.67%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 22.05% 90.31% 94.88% 97.87% -916.52%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 463.74% 68.83% 607.89% 874.83% -154.17%